Thursday, December 6, 2007

Mesothelioma News Blog Archive "phase III clinical trials pleural mesothelioma

Emory Winship Cancer Institute will be one of two facilities in Georgia to conduct a clinical trial phase III of Vorinostat (oral suberoylanilide hydromaxic acid) in patients with advanced cancer pleural "mesothelioma". ... - continue reading...